No Data
Emergent BioSolutions Inc. (NYSE:EBS) Analysts Are Pretty Bullish On The Stock After Recent Results
Express News | Benchmark Reiterates Buy on Emergent BioSolutions, Maintains $8 Price Target
Emergent BioSolutions Analyst Ratings
Emergent BioSolutions | 10-Q: Q2 2024 Earnings Report
Vaccine Maker Emergent BioSolutions Expects Deeper Losses In 2024, Stock Sinks
Express News | Emergent BioSolutions Shares Fall 38.4% on Wider-Than-Expected Q2 Loss
EZ_money OP : still maintaining buy rating